ANTIHYPERTENSIVE ACTIVITY OF ALACEPRIL, AN ORALLY ACTIVE ANGIOTENSIN CONVERTING ENZYME-INHIBITOR, IN RENAL HYPERTENSIVE RATS AND DOGS

被引：0
|
作者：
TAKEYAMA, K
MINATO, H
FUKUYA, F
KAWAHARA, S
HOSOKI, K
KADOKAWA, T
机构：
来源：
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 1985年 / 35-2卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：1502 / 1507
页数：6
相关论文
共 50 条
  • [1] HYPOTENSIVE ACTIVITY OF AN ORALLY ACTIVE CONVERTING ENZYME-INHIBITOR IN SPONTANEOUSLY HYPERTENSIVE RATS
    HUTCHINSON, JS
    MENDELSOHN, FAO
    DOYLE, AE
    DUFFY, S
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1979, 6 (06) : 676 - 676
  • [2] HEMODYNAMIC AND ANTIHYPERTENSIVE EFFECTS OF CAPTOPRIL, AN ORALLY ACTIVE ANGIOTENSIN CONVERTING ENZYME-INHIBITOR
    SULLIVAN, JM
    GINSBURG, BA
    RATTS, TE
    JOHNSON, JG
    BARTON, BR
    KRAUS, DH
    MCKINSTRY, DN
    MUIRHEAD, EE
    HYPERTENSION, 1979, 1 (04) : 397 - 401
  • [3] ANTIHYPERTENSIVE ACTION OF ORALLY ACTIVE CONVERTING ENZYME-INHIBITOR (SQ-14,225) IN SPONTANEOUSLY HYPERTENSIVE RATS
    MUIRHEAD, EE
    PREWITT, RL
    BROOKS, B
    BROSIUS, WL
    CIRCULATION RESEARCH, 1978, 43 (01) : I53 - I59
  • [4] EFFECTS OF SODIUM LOADING ON ANTIHYPERTENSIVE RESPONSES TO AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR IN SPONTANEOUSLY HYPERTENSIVE AND RENAL HYPERTENSIVE RATS
    NAKATA, K
    TAKADA, T
    YAMAUCHI, H
    ISO, T
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 121 (02) : 293 - 295
  • [5] ANTIHYPERTENSIVE EFFECT OF ENALAPRIL MALEATE, AN ANGIOTENSIN CONVERTING ENZYME-INHIBITOR, IN EXPERIMENTAL HYPERTENSIVE RATS
    IKEDA, N
    MAKI, E
    NARUSE, T
    ASAMI, T
    OHMURA, I
    FOLIA PHARMACOLOGICA JAPONICA, 1985, 86 (03) : P23 - P23
  • [6] ANTIHYPERTENSIVE ACTIVITY OF SQ 14225, AN ORALLY ACTIVE INHIBITOR OF ANGIOTENSIN CONVERTING ENZYME
    LAFFAN, RJ
    GOLDBERG, ME
    HIGH, JP
    SCHAEFFER, T
    WAUGH, MH
    RUBIN, B
    FEDERATION PROCEEDINGS, 1977, 36 (03) : 1049 - 1049
  • [7] PHARMACODYNAMICS AND PHARMACOKINETICS OF A NEW ORALLY ACTIVE ANGIOTENSIN-I-CONVERTING ENZYME-INHIBITOR, ALACEPRIL (DU-1219), IN NORMAL SUBJECTS AND HYPERTENSIVE PATIENTS
    OGIHARA, T
    NAKAMARU, M
    HIGAKI, J
    KUMAHARA, Y
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1987, 41 (04): : 492 - 508
  • [8] ANTIHYPERTENSIVE ACTION OF A NOVEL ORALLY ACTIVE ANGIOTENSIN CONVERTING ENZYME-INHIBITOR ALTIOPRIL CALCIUM (MC-838) IN SEVERAL HYPERTENSIVE MODELS OF RATS - COMPARISON WITH CAPTOPRIL
    AONO, J
    KOGA, T
    YAMAZAKI, T
    SHIRAKI, Y
    SAKAI, K
    ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1988, 292 : 203 - 222
  • [9] CHRONIC ANTIHYPERTENSIVE EFFECTS OF CAPTOPRIL (SQ-14,225) - ORALLY ACTIVE ANGIOTENSIN I-CONVERTING ENZYME-INHIBITOR, IN CONSCIOUS 2-KIDNEY RENAL HYPERTENSIVE RATS
    RUBIN, B
    ANTONACCIO, MJ
    GOLDBERG, ME
    HARRIS, DN
    ITKIN, AG
    HOROVITZ, ZP
    PANASEVICH, RE
    LAFFAN, RJ
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 51 (04) : 377 - 388
  • [10] TREATMENT OF HYPERTENSION WITH AN ORALLY ACTIVE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR (CAPTOPRIL)
    DEBRUYN, JHB
    SCHALEKAMP, MADH
    NETHERLANDS JOURNAL OF MEDICINE, 1979, 22 (05): : 179 - 180
12345